FDA Public Information Strategy Is “Dangerous” And “Imprecise” – AEI Fellow

FDA's increasing reliance on public health advisories to convey drug safety information is "dangerous" because the messages do not target the appropriate audience, American Enterprise Institute Resident Fellow Scott Gottlieb said